Alejandra Preciado

Associate Director, Financial Planning & Analysis at Corcept Therapeutics

Alejandra Preciado, CPA, currently serves as a Senior Manager in both Financial Planning & Analysis and SEC Reporting & Technical Accounting at Corcept Therapeutics since March 2021, after progressing through roles as Manager in SEC Reporting & Technical Accounting. Prior to Corcept Therapeutics, Alejandra held multiple positions at Connor Group from February 2017 to March 2021, starting as a Senior in Technical Accounting and advancing to Manager. Additional experience includes a role as a Senior Revenue Analyst at Veritas Technologies LLC from March 2016 to January 2017 and earlier positions in Assurance Services at EY from September 2013 to March 2016. Alejandra earned a Bachelor of Commerce degree in Accounting and Sociology from Santa Clara University Leavey School of Business, graduating in 2013.

Location

San Jose, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Corcept Therapeutics

4 followers

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders.


Industries

Employees

201-500

Links